Literature DB >> 7488446

Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction.

R Senior1, B Glenville, S Basu, B S Sridhara, E Anagnostou, R Stanbridge, S J Edmondson, C E Handler, E B Raftery, A Lahiri.   

Abstract

OBJECTIVES: To evaluate the concordance between thallium-201 uptake and echocardiographic wall thickening, which are both indicators of potentially reversible myocardial dysfunction, in patients with chronic ischaemic left ventricular failure and to assess their relative contribution to predicting improvement in regional function after revascularisation in a subgroup. PATIENTS AND METHODS: 45 patients with chronic ischaemic left ventricular dysfunction (mean (SD) ejection fraction 25 (8)%) underwent echocardiography before and after dobutamine infusion (10 micrograms/kg/min). Of these, 22 patients underwent rest echocardiography at a mean (SD) of 9 (1) weeks after revascularisation. 201Tl imaging was performed during dobutamine echocardiography and at rest, 1, and 4 h after treatment with sublingual glyceryl trinitrate on two separate days. Potentially reversible dysfunction was thought to be present when a myocardial segment contained a Tl score of > or = 3 (ascending score 1-4), or showed improved wall thickening of a dysynergic segment during dobutamine stimulation.
RESULTS: Of the 201Tl protocols, the redistribution scan 1 h after treatment with glyceryl trinitrate best demonstrated myocardial viability. Concordance between 201Tl and dobutamine induced wall thickening was 82% (kappa = 0.59) for detecting potentially reversible myocardial dysfunction before revascularisation (n = 45). Regional function improved in 18 of 22 patients after revascularisation. There were 168 dysynergic segments before intervention. The sensitivity of echocardiography and 201Tl imaging for detecting "recoverable" or viable segments after revascularisation was 87% and 92% respectively and specificity was 82% and 78% respectively (P = NS).
CONCLUSIONS: Dobutamine echocardiography and 201Tl imaging may be used to predict mechanical improvement in dysynergic segments after revascularisation in patients with chronic ischaemic left ventricular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488446      PMCID: PMC484038          DOI: 10.1136/hrt.74.4.358

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  26 in total

1.  Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest.

Authors:  E Picano; P Marzullo; G Gigli; B Reisenhofer; O Parodi; A Distante; A L'Abbate
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

2.  Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation.

Authors:  R Schulz; B D Guth; K Pieper; C Martin; G Heusch
Journal:  Circ Res       Date:  1992-06       Impact factor: 17.367

3.  Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine. The epinephrine ventriculogram.

Authors:  H R Horn; L E Teichholz; P F Cohn; M V Herman; R Gorlin
Journal:  Circulation       Date:  1974-06       Impact factor: 29.690

4.  Reversible asynergy. Histopathologic and electrographic correlations in patients with coronary artery disease.

Authors:  M M Bodenheimer; V S Banka; G A Hermann; R G Trout; H Pasdar; R H Helfant
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

5.  Nitroglycerin to unmask reversible asynergy. Correlation with post coronary bypass ventriculography.

Authors:  R H Helfant; R Pine; S G Meister; M S Feldman; R G Trout; V S Banka
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

6.  Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function.

Authors:  M Ragosta; G A Beller; D D Watson; S Kaul; L W Gimple
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

7.  Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi.

Authors:  J E Udelson; P S Coleman; J Metherall; N G Pandian; A R Gomez; J L Griffith; N L Shea; E Oates; M A Konstam
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

8.  Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization.

Authors:  C G Cigarroa; C R deFilippi; M E Brickner; L G Alvarez; M A Wait; P A Grayburn
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

9.  Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.

Authors:  V Dilsizian; P Perrone-Filardi; J A Arrighi; S L Bacharach; A A Quyyumi; N M Freedman; R O Bonow
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

10.  Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT.

Authors:  Z X He; J Darcourt; A Guignier; E Ferrari; F Bussière; M Baudouy; P Morand
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

View more
  13 in total

Review 1.  Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

Authors:  J L Vanoverschelde; A Pasquet; B Gerber; J A Melin
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?

Authors:  Z X He; M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

Review 3.  Evolving therapeutic concepts and imaging in ischemic cardiomyopathy.

Authors:  A Lahiri; R Senior
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 4.  Stress echocardiography for assessing myocardial ischaemia and viable myocardium.

Authors:  R Senior; A Kenny; P Nihoyannopoulos
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

5.  Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease.

Authors:  R S Khattar; R Senior; A Lahiri
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

Review 6.  Diagnostic and imaging considerations: role of viability.

Authors:  Roxy Senior
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

7.  Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients.

Authors:  S Basu; R Senior; C Dore; A Lahiri
Journal:  BMJ       Date:  1996-10-05

8.  Comparison of arbutamine stress 99mTc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia.

Authors:  R S Khattar; R Senior; D Joseph; A Lahiri
Journal:  J Nucl Cardiol       Date:  1997 May-Jun       Impact factor: 5.952

9.  Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging.

Authors:  R Senior; A Lahiri
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

10.  Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography.

Authors:  P Soman; R Khattar; R Senior; A Lahiri
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.